01 October 2018

During the exhibition, we distributed the latest edition of a catalogue about the sustained-release transfection reagent AteloGene, which has been widely used for in vivo administration of anti-tumour siRNA/miRNA.

We thank the attendees who visited our booth.

Name	The 77th Annual Meeting of the Japanese Cancer Association
URL	https://www.congre.co.jp/jca2018/index_en.php
Date	27-29 September 2018
Venue	Osaka International Convention Center, Osaka, Japan
Booth No.	3-49